Digoxin use is associated with pancreatic cancer risk but does not affect survival.

Saved in:
Bibliographic Details
Title: Digoxin use is associated with pancreatic cancer risk but does not affect survival.
Authors: Boursi B; Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Tel-Aviv University, Tel-Aviv, Israel. ben.boursi@sheba.health.gov.il.; Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel. ben.boursi@sheba.health.gov.il., Huber JS; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Haynes K; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Mamtani R; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Yang YX; Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Source: Cancer causes & control : CCC [Cancer Causes Control] 2021 Jan; Vol. 32 (1), pp. 41-46. Date of Electronic Publication: 2020 Oct 16.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9100846 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7225 (Electronic) Linking ISSN: 09575243 NLM ISO Abbreviation: Cancer Causes Control Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33064241
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Digoxin use is associated with pancreatic cancer risk but does not affect survival.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Boursi+B%22">Boursi B</searchLink>; Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ben.boursi@sheba.health.gov.il.; Tel-Aviv University, Tel-Aviv, Israel. ben.boursi@sheba.health.gov.il.; Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel. ben.boursi@sheba.health.gov.il.<br /><searchLink fieldCode="AU" term="%22Huber+JS%22">Huber JS</searchLink>; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Haynes+K%22">Haynes K</searchLink>; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mamtani+R%22">Mamtani R</searchLink>; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Yang+YX%22">Yang YX</searchLink>; Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229100846%22">Cancer causes & control : CCC</searchLink> [Cancer Causes Control] 2021 Jan; Vol. 32 (1), pp. 41-46. <i>Date of Electronic Publication: </i>2020 Oct 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic+Publishers%22">Kluwer Academic Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9100846 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7225 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209575243%22">09575243 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Causes Control <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33064241
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10552-020-01352-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 41
    Titles:
      – TitleFull: Digoxin use is associated with pancreatic cancer risk but does not affect survival.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Boursi B
      – PersonEntity:
          Name:
            NameFull: Huber JS
      – PersonEntity:
          Name:
            NameFull: Haynes K
      – PersonEntity:
          Name:
            NameFull: Mamtani R
      – PersonEntity:
          Name:
            NameFull: Yang YX
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2021 Jan
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7225
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer causes & control : CCC
              Type: main
ResultId 1